Dr. Berard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
425 Post Rd
Fairfield, CT 06824Phone+1 203-255-4545Fax+1 203-254-1191
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
Berkshire Medical CenterResidency, Internal Medicine, 1985 - 1988
Uconn School Of MedicineClass of 1985
Certifications & Licensure
CT State Medical License 1991 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 May 15
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsExcessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase.Howard A. Liebman, Mary K. Carfagno, Ilene C. Weitz, Paul Berard, Jere M. Diiorio
American Journal of Clinical Pathology. 1992-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
